CECR7: A Drug Target / Disease Biomarker (G100130418)

Target Name: CECR7

NCBI ID: G100130418

CECR7

Other Name(s): cat eye syndrome chromosome region, candidate 7 | SAHL1 | CYCL | CECR7 variant 1 | Cat eye syndrome chromosome region, candidate 7, transcript variant 1

CECR7: A Drug Target / Disease Biomarker

CECR7 is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and muscle. Its full name is cytoskeleton-associated protein 7, and it is also known as DAF162. CECR7 is a protein that is made up of 21 kDa, and it is localized to the cytoskeleton.

The cytoskeleton is a protein that is responsible for giving cells their shape and structure. It is made up of a network of filaments and cytoskeleton protein, which help to shape the cell and give it its characteristic shape. The cytoskeleton is also involved in cell division and transport of organelles within the cell.

CECR7 is a protein that is specifically localized to the cytoskeleton. It is made up of 21 kDa and is located in the cytoskeleton network. It is known to be involved in the regulation of cell division and the maintenance of the cytoskeleton.

One of the functions of CECR7 is to regulate the assembly and disassembly of microtubules in the cytoskeleton. Microtubules are the protein structures that make up the cytoskeleton and they help to shape the cell. The assembly and disassembly of microtubules is critical for the proper functioning of the cell.

Another function of CECR7 is to regulate the attachment of organelles to the cytoskeleton. Organelles are small structures that are found in the cytoskeleton, such as mitochondria, ribosomes, and the endoplasmic reticulum. These organelles play a critical role in the cell's metabolism and are involved in the production of proteins, RNA, and other molecules.

CECR7 is also involved in the regulation of cell death. When a cell is no longer needed, it can undergo a process called apoptosis, which is a controlled form of cell death. The regulation of cell death is important for maintaining the health and diversity of the cell population.

CECR7 is also involved in the regulation of the cytoskeleton's flexibility. The cytoskeleton is a network of filaments and proteins that help to shape the cell. The flexibility of the cytoskeleton is important for the cell's movement and other functions. CECR7 is involved in the regulation of the cytoskeleton's flexibility, which is critical for the cell's proper functioning.

CECR7 is also involved in the regulation of the cytoskeleton's stability. The cytoskeleton is a network of filaments and proteins that help to shape the cell. The stability of the cytoskeleton is important for the cell's proper functioning. CECR7 is involved in the regulation of the cytoskeleton's stability, which is critical for the cell's long-term survival.

In conclusion, CECR7 is a protein that is localized to the cytoskeleton and is involved in the regulation of cell division, attachment of organelles, cell death, cytoskeleton's flexibility, and stability. These functions are critical for the proper functioning of the cell and are of great interest for the development of new drugs and biomarkers.

Protein Name: Cat Eye Syndrome Chromosome Region, Candidate 7

The "CECR7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CECR7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets